CPT code 17260: What it covers and what Medicare pays

Key takeaways

CPT code 17260 reports destruction of a malignant skin lesion on the trunk, arms, or legs, measuring 0.5 cm or less.

The lesion is measured at its widest point before treatment, and 0.6 cm moves the claim to CPT code 17261.

Medicare’s 2026 non-facility payment runs from roughly $123 to $180, so check your own locality rate before you quote a figure.

Report the most complex lesion first with no modifier, then add modifier 51 to every additional lesion destroyed that day.

Structured intake forms and treatment notes capture diameter, site, and method in the room, which is where most denials are prevented.

CPT code 17260 covers destruction of a malignant skin lesion on the trunk, arms, or legs, when that lesion measures 0.5 cm or less.

Most denials on this code start in the treatment room, not in the billing office. A note that reads “small lesion, left arm” carries no measurement and no side. A coder cannot defend a size-based code from that, so the claim goes out weak and comes back unpaid.

What CPT code 17260 actually covers

The official descriptor from the American Medical Association is exact. It reads: Destruction, malignant lesion (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), trunk, arms, or legs; lesion diameter 0.5 cm or less.

Four things follow from that wording, and each one shows up in denial letters:

• The listed methods are examples, not a closed list. Electrodessication and curettage, photodynamic therapy, and topical chemosurgery all sit inside the code when they treat a confirmed malignancy.
• The anatomical scope is fixed. Trunk, arms, and legs qualify, and nothing else does. Scalp, neck, hands, feet, and genitalia move to 17270-17276. Face, ears, eyelids, nose, lips, and mucous membrane move to 17280-17286.
• The size threshold is absolute. A lesion measured at 0.6 cm belongs to CPT code 17261, with no rounding in either direction. Measure at the widest point before anything is destroyed.
• Malignancy has to be established. Premalignant work, such as actinic keratosis destruction, belongs with CPT code 17000 instead.

Where 17260 sits in the wider destruction range

CPT code 17260 is the entry point of a tiered range organized first by body region, then by lesion diameter. Picking the wrong rung is one of the most common findings in dermatology billing audits.

The table below maps each code to its region and size band.

Code 17265 does not exist, so the trunk, arm, and leg ladder jumps straight from 17264 to 17266. Facial sites run on a separate ladder that starts at CPT code 17280 and climbs through CPT code 17284.

What Medicare pays for 17260 in 2026

Payment lands between roughly $123 and $180 in the office setting, and your locality decides where in that band you sit.

The Geographic Practice Cost Index moves the figure by region, so a national average is a starting point rather than an answer. Check your own rate in the CMS fee schedule lookup tool before quoting anything internally.

The RVUs behind that payment

Relative Value Units, known as RVUs, are what Medicare multiplies by the conversion factor to reach a payment. Three components make up the total, and the work component has held steady across recent fee schedule files.

Practice expense is the component that swings, because the office setting absorbs costs a hospital would carry. Pull the current numbers straight from the CMS relative value files when you build revenue projections.

Coverage depends on documented medical necessity

Medicare covers destruction of a malignant skin lesion when the record shows why it was needed. The detail is set locally, through the Local Coverage Determination issued by each Medicare Administrative Contractor, or MAC.

Four conditions turn up in almost every one of them:

1. A confirmed or clinically suspected malignancy supports the claim, evidenced by biopsy results or a documented clinical assessment.
2. The provider performs the procedure within the scope of their license.
3. The record states the destruction method, the anatomical location, and the pre-treatment diameter.
4. The ICD-10-CM code reflects a malignant condition. Cosmetic destruction of a benign lesion is never covered.

Some MACs go further and want pathology confirmation, or even prior authorization, before the procedure rather than after it. That changes how you schedule, not just how you bill.

Read your own MAC’s coverage article for this code once, then build its requirements into the booking process.

Pair the code with an ICD-10-CM diagnosis that matches

Every 17260 claim needs a diagnosis code that establishes malignancy in the same region you treated. A trunk lesion paired with an arm diagnosis fails, and a benign diagnosis fails faster.

The table below lists the pairings that come up most often.

Your MAC’s coverage article lists the diagnosis codes it accepts. It will not take every option in the C44 family without extra documentation. Check the list once a year, because it moves.

Modifiers change how a payer reads the claim

Four modifiers do almost all the work on this code, and one of them carries real audit risk.

The National Correct Coding Initiative tracks modifier patterns at the claim and provider level. Use each one only when the clinical picture genuinely supports it.

Modifier 59 draws more scrutiny than the rest of this range put together. The NCCI policy manual limits it to procedures that are distinct at the anatomical site level, not merely on different parts of the body. When you use it here, put the reason in the procedure note the same day.

Billing two or more lesions in one visit

Report the most complex lesion first with no modifier, then add modifier 51 to each additional lesion. Most complex means the highest paying code, which usually means the largest lesion. A worked example makes the order concrete.

Say a provider treats three malignant lesions at one visit:

1. Trunk, 1.3 cm, which is CPT code 17262
2. Arm, 0.4 cm, which is CPT code 17260
3. Leg, 0.8 cm, which is CPT code 17261

The claim lists 17262 first with no modifier, then 17261 with modifier 51, then 17260 with modifier 51. Reverse that order and you invite an underpayment, because the reduction gets applied to the wrong line.

Medicare pays the primary procedure in full and typically halves the additional ones, though reduction schedules vary by payer.

How the claim moves from treatment room to payment

A 17260 claim passes through four sets of hands before it becomes money. Seeing the order helps you spot where yours tends to stall.

1. The provider identifies a suspicious lesion and records the clinical basis for malignancy. A biopsy such as CPT code 11102 usually settles the question first.
2. At the treatment visit, the lesion is measured at its widest point and then destroyed. Diameter, site, side, and method all go into the note.
3. The coder builds the claim from that note. The measurement picks the code, not the provider’s description of the lesion.
4. The claim reaches the MAC, which checks the diagnosis pairing, runs the NCCI edits, and may ask for the record.

Stalls almost always trace back to step two. Everything downstream depends on a number that takes five seconds to write down while the patient is still in the chair.

Documentation that keeps a 17260 claim clean

The chart has to support all three defining criteria: malignancy, location, and diameter. Strong clinical documentation practices and a consistent progress note format prevent most of them.

• Pre-treatment diameter. Measured at the widest point and recorded in centimeters, never as “small” or “pinpoint”.
• Anatomical location. Region plus side, so “left forearm” rather than “upper extremity”. Vague sites get flagged on audit.
• Destruction method. Name the technique used, whether that is electrodessication, cryosurgery, or laser.
• Malignancy confirmation. A prior pathology report, or a documented clinical assessment explaining why the lesion looked malignant.
• Medical necessity statement. One line on why destruction was the right treatment, rather than excision or watchful waiting.

Paper capture is where these details go missing, because nothing on the page forces the measurement to be written.

Digital intake forms with a lesion measurement field close that off at the source. HIPAA-compliant recordkeeping then keeps the note retrievable when an auditor asks for it two years later.

Run this check before you submit

Six things are worth confirming while the claim is still yours to fix. Each one takes seconds now and saves an appeal later.

1. The diameter is recorded in centimeters and was measured before destruction.
2. The note names the body region and the side, not just the limb.
3. The destruction method appears in the record.
4. The ICD-10-CM code shows a malignant lesion in the region you treated.
5. The most complex lesion sits first, with modifier 51 on the rest.
6. Modifier 25 is attached if you also billed a visit such as CPT code 99213.

Where 17260 claims usually go wrong

Denials on this code cluster around the same five mistakes. Each one is a workflow fix rather than a coding puzzle.

• The wrong size band. A 0.5 cm lesion is 17260 and a 0.55 cm lesion is 17261. There is no interpretation here, so train staff to measure and record before every destruction.
• An ambiguous region. The shoulder gets coded to the trunk by some practices and to the arm by others. Set one practice-wide policy that matches your MAC, write it down, and follow it.
• Unbundling with excision. A lesion is either destroyed or excised. That means this code cannot be billed alongside an excision code such as CPT code 11606 on the same date, for the same lesion. If the plan changes mid-procedure, bill the excision only.
• Benign codes in a malignant slot. Destruction of benign or vascular lesions has its own codes, including CPT code 17106. Pair a benign diagnosis with 17260 and the claim denies on arrival.
• No malignancy evidence. Submitting without a pathology report or a written clinical rationale is the single largest source of medical necessity denials on this code.

How Pabau keeps dermatology documentation billing-ready

Most 17260 denials trace back to a note written in a hurry. The provider did the work correctly and the coder read the note carefully, but there was no diameter in it. In a busy skin practice, that note gets typed between patients, which is exactly when details drop out.

Practice management software like Pabau moves that capture into the clinician’s hands. For a dermatology practice, intake forms and treatment notes can hold set fields for diameter, site, side, and destruction method. The measurement gets entered as a number in the room, rather than reconstructed from memory a week later.

Behind that, patient records keep every prior measurement, pathology reference, and treatment date in one retrievable file, which is what an audit request asks for.

Claims management then holds the insurer and policy detail and handles submission. Your coder still chooses the code, but now with a complete note to choose from.

Send dermatology claims out with complete notes

Structured forms and treatment notes in Pabau capture lesion size, site, and destruction method while the patient is still in the room. Your team codes from a complete record instead of chasing the provider for details.

Book a demo

Conclusion

CPT code 17260 has three hard edges: malignant, trunk or arm or leg, and 0.5 cm or less. Move any one of them and you are in a different code. The measurement is what decides the money, so it belongs in the note before the destruction starts.

Fix the capture and the rest of the claim tends to look after itself. Practices that measure, name the site, and record the method rarely end up arguing with a payer months later.

To see how Pabau keeps that detail in the chart and your dermatology claims clean, book a demo.

Continue your research

Treating a much larger lesion on the trunk? CPT code 17266 covers the top tier of the same trunk, arm, and leg range.

Destroying a vascular lesion rather than a cancer? CPT code 17107 sets out the rules for cutaneous vascular proliferative lesions.

Need the biopsy that confirms malignancy first? CPT code 11104 explains punch biopsy billing and the add-on code for extra lesions.

Tracking lesions across repeat visits? Full body mole mapping shows how systematic lesion tracking supports clinical and billing accuracy.

Reviewing how your claims are submitted? Pabau vs Waystar compares two very different approaches to claims management.

Frequently asked questions